Newton Charles W.

Insider profile

Performance

Overall performance
1.5

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -22% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return -6%
Success rate 73%
Average holding period 220
Transactions 28
Newton Charles W.'s trades of Lyell Immunopharma Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-08-22 2025-08-21 S Sale
38,621 -31.0%
376.98
US$1,509,913
38,621 -31.0% 376.98 US$1,509,913
2025-08-13 2025-08-12 S Sale
43,170 -30.6%
231.11
US$379,612
43,170 -30.6% 231.11 US$379,612
2025-08-13 2025-08-11 PlS Planned sale
28,887 -21.1%
281.33
US$2,907,500
28,887 -21.1% 281.33 US$2,907,500
2025-03-18 2025-03-17 B Purchase
200,000 +inf%
0.56
US$111,620
200,000 +inf% 0.56 US$111,620